SHELTON, CONNECTICUT / ACCESS Newswire / August 18, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC ...

Tivic Health (TIVC) announced it has received, from Statera Biopharma (STAB), two investigational new drug applications for its lead candidate, ...

In recent years, cell biology has been revolutionized by applying emerging bio/nanomaterials. These advancements, ...

MBX Biosciences Inc. (NASDAQ: MBX) is one of the best IPO stocks to buy according to Wall Street analysts. On June 16, MBX ...

Jaguar Health, Inc. ( NASDAQ: JAGX) Q2 2025 Earnings Conference Call August 14, 2025 8:30 AM ET Carol R. Lizak - Chief Financial Officer Lisa A. Conte - Founder, CEO, President & Director ...

The extension was needed to review newly submitted long-term clinical data for all patients in the pivotal study following an FDA information request.

Within the past few years, models that can predict the structure or function of proteins have been widely used for a variety ...

Event highlights San Diego’s vital role in biotech innovation and UC San Diego’s commitment to research, patients and ...

The FDA has approved Insmed’s Brinsupri™ (brensocatib 10 mg and 25 mg tablets) as the first drug authorized to treat ...

Federal health officials are warning sunscreen companies for violating drug regulations by selling products in unapproved ...

The alert follows a wave of warning letters the agency sent to Supergoop!, Vacation Inc. and three other popular brands, accusing them of peddling whipped, mousse and foam sunscreens that flout ...

Net loss (GAAP) narrowed to $6.1 million in Q2 2025, a 22.8% improvement from the prior-year period, driven by reduced research and development spending. No product revenue reported; The company’s ...